|Day Low/High||109.48 / 110.49|
|52 Wk Low/High||101.42 / 142.50|
Pharmacopeia gets a big lift after announcing a drug discovery pact with Cephalon.
The cycle we've seen since late November implies we'll see a pullback of two to three weeks.
Instead of vaulting old highs on good Arms Index numbers, indices have been reluctant to get going.
Alexion jumps on positive trial results, while CNS falls after a weak profit report.
A recent rash of new bankruptcy filings is good news for Portfolio Recovery Associates, says Cramer.
Cramer says the French oil company is a celestial buy. Also, the eve of construction.
Strength in the conglomerate's divisions should have sector ripple effects, Cramer says.
Bulls stay the course as semiconductor stocks sell off for the second day in a row.
Energy and defense for sure, but commodities, utilities and even two Internet stocks make it.
The medical equipment company says order growth in its oncology business has been strong.
It's a good time to raise cash. Also, charts of Coors, Qualcomm and others.
As the larger indices bounce within channels, many stocks aren't moving with the market.
If you're an impatient trader, here's a way to play Fluor, Expedia, Textron and more.
A brutal week tapered off with some tech stocks fighting bad news.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.